These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12810152)

  • 1. Biochemical studies of apoptosis induced by tamoxifen in estrogen receptor positive and negative breast cancer cell lines.
    Salami S; Karami-Tehrani F
    Clin Biochem; 2003 Jun; 36(4):247-53. PubMed ID: 12810152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equol enhances tamoxifen's anti-tumor activity by induction of caspase-mediated apoptosis in MCF-7 breast cancer cells.
    Charalambous C; Pitta CA; Constantinou AI
    BMC Cancer; 2013 May; 13():238. PubMed ID: 23675643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
    Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
    Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells.
    Mandlekar S; Yu R; Tan TH; Kong AN
    Cancer Res; 2000 Nov; 60(21):5995-6000. PubMed ID: 11085519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cells.
    Kallio A; Zheng A; Dahllund J; Heiskanen KM; Härkönen P
    Apoptosis; 2005 Dec; 10(6):1395-410. PubMed ID: 16215679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of PKC-ERK signaling in tamoxifen-induced apoptosis and tamoxifen resistance in human breast cancer cells.
    Li Z; Wang N; Fang J; Huang J; Tian F; Li C; Xie F
    Oncol Rep; 2012 Jun; 27(6):1879-86. PubMed ID: 22427054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of c-myc in tamoxifen-induced apoptosis estrogen-independent breast cancer cells.
    Kang Y; Cortina R; Perry RR
    J Natl Cancer Inst; 1996 Mar; 88(5):279-84. PubMed ID: 8614006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vitamin E on tamoxifen-treated breast cancer cells.
    Peralta EA; Viegas ML; Louis S; Engle DL; Dunnington GL
    Surgery; 2006 Oct; 140(4):607-14; discussion 614-5. PubMed ID: 17011908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53-independent dephosphorylation and cleavage of retinoblastoma protein during tamoxifen-induced apoptosis in human breast carcinoma cells.
    Fattman CL; An B; Sussman L; Dou QP
    Cancer Lett; 1998 Aug; 130(1-2):103-13. PubMed ID: 9751262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of HER2 modulates bcl-2, bcl-XL, and tamoxifen-induced apoptosis in human MCF-7 breast cancer cells.
    Kumar R; Mandal M; Lipton A; Harvey H; Thompson CB
    Clin Cancer Res; 1996 Jul; 2(7):1215-9. PubMed ID: 9816290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inositol hexaphosphate (IP6) enhances the anti-proliferative effects of adriamycin and tamoxifen in breast cancer.
    Tantivejkul K; Vucenik I; Eiseman J; Shamsuddin AM
    Breast Cancer Res Treat; 2003 Jun; 79(3):301-12. PubMed ID: 12846414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression.
    Raha P; Thomas S; Thurn KT; Park J; Munster PN
    Breast Cancer Res; 2015 Feb; 17(1):26. PubMed ID: 25848915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinatorial anti-proliferative effects of tamoxifen and naringenin: The role of four estrogen receptor subtypes.
    Xu Z; Huang B; Liu J; Wu X; Luo N; Wang X; Zheng X; Pan X
    Toxicology; 2018 Dec; 410():231-246. PubMed ID: 30153467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of apoptosis and/or necrosis following exposure to antitumour agents in a melanoma cell line, probably through modulation of Bcl-2 family proteins.
    Shibuya H; Kato Y; Saito M; Isobe T; Tsuboi R; Koga M; Toyota H; Mizuguchi J
    Melanoma Res; 2003 Oct; 13(5):457-64. PubMed ID: 14512787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tanshinone I effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells.
    Nizamutdinova IT; Lee GW; Son KH; Jeon SJ; Kang SS; Kim YS; Lee JH; Seo HG; Chang KC; Kim HJ
    Int J Oncol; 2008 Sep; 33(3):485-91. PubMed ID: 18695877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen-induced apoptosis in breast cancer cells relates to down-regulation of bcl-2, but not bax and bcl-X(L), without alteration of p53 protein levels.
    Zhang GJ; Kimijima I; Onda M; Kanno M; Sato H; Watanabe T; Tsuchiya A; Abe R; Takenoshita S
    Clin Cancer Res; 1999 Oct; 5(10):2971-7. PubMed ID: 10537367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Centchroman induces G0/G1 arrest and caspase-dependent apoptosis involving mitochondrial membrane depolarization in MCF-7 and MDA MB-231 human breast cancer cells.
    Nigam M; Ranjan V; Srivastava S; Sharma R; Balapure AK
    Life Sci; 2008 Mar; 82(11-12):577-90. PubMed ID: 18279897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive resistance to apoptosis in a cell lineage model of human proliferative breast disease.
    Starcevic SL; Elferink C; Novak RF
    J Natl Cancer Inst; 2001 May; 93(10):776-82. PubMed ID: 11353788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of tamoxifen sensitivity by antisense Bcl-2 and trastuzumab in breast carcinoma cells.
    Kim R; Tanabe K; Emi M; Uchida Y; Toge T
    Cancer; 2005 May; 103(10):2199-207. PubMed ID: 15830342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of the death gene BIK is a critical factor for resistance to tamoxifen in MCF-7 breast cancer cells.
    Viedma-Rodriguez R; Baiza-Gutman LA; García-Carrancá A; Moreno-Fierros L; Salamanca-Gómez F; Arenas-Aranda D
    Int J Oncol; 2013 Dec; 43(6):1777-86. PubMed ID: 24100375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.